
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Morten F. Gjerstorff, Mads Hald Andersen, Henrik J. Ditzel
Oncotarget (2015) Vol. 6, Iss. 18, pp. 15772-15787
Open Access | Times Cited: 307
Morten F. Gjerstorff, Mads Hald Andersen, Henrik J. Ditzel
Oncotarget (2015) Vol. 6, Iss. 18, pp. 15772-15787
Open Access | Times Cited: 307
Showing 1-25 of 307 citing articles:
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel, Diego Chowell, Timothy A. Chan
Nature reviews. Cancer (2019) Vol. 19, Iss. 3, pp. 133-150
Open Access | Times Cited: 1956
Jonathan J. Havel, Diego Chowell, Timothy A. Chan
Nature reviews. Cancer (2019) Vol. 19, Iss. 3, pp. 133-150
Open Access | Times Cited: 1956
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 897
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 897
Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 526
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 526
Teaching an old dog new tricks: next-generation CAR T cells
Nicholas Tokarew, Justyna Ogonek, Stefan Endres, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 26-37
Open Access | Times Cited: 347
Nicholas Tokarew, Justyna Ogonek, Stefan Endres, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 26-37
Open Access | Times Cited: 347
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Remy Thomas, Ghaneya Al‐Khadairi, Jessica Roelands, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 329
Remy Thomas, Ghaneya Al‐Khadairi, Jessica Roelands, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 329
Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma
Tomonori Sasahira, Tadaaki Kirita
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2413-2413
Open Access | Times Cited: 242
Tomonori Sasahira, Tadaaki Kirita
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2413-2413
Open Access | Times Cited: 242
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Breast cancer genomics and immuno-oncological markers to guide immune therapies
Dora Hammerl, Marcel Smid, A. Mieke Timmermans, et al.
Seminars in Cancer Biology (2017) Vol. 52, pp. 178-188
Open Access | Times Cited: 136
Dora Hammerl, Marcel Smid, A. Mieke Timmermans, et al.
Seminars in Cancer Biology (2017) Vol. 52, pp. 178-188
Open Access | Times Cited: 136
The lymph node pre-metastatic niche
Jonathan P. Sleeman
Journal of Molecular Medicine (2015) Vol. 93, Iss. 11, pp. 1173-1184
Closed Access | Times Cited: 132
Jonathan P. Sleeman
Journal of Molecular Medicine (2015) Vol. 93, Iss. 11, pp. 1173-1184
Closed Access | Times Cited: 132
Cancer Vaccines
Peter J. DeMaria, Marijo Bilušić
Hematology/Oncology Clinics of North America (2019) Vol. 33, Iss. 2, pp. 199-214
Closed Access | Times Cited: 113
Peter J. DeMaria, Marijo Bilušić
Hematology/Oncology Clinics of North America (2019) Vol. 33, Iss. 2, pp. 199-214
Closed Access | Times Cited: 113
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements
Rebecca A. Luchtel, Surendra Dasari, Naoki Oishi, et al.
Blood (2018) Vol. 132, Iss. 13, pp. 1386-1398
Open Access | Times Cited: 109
Rebecca A. Luchtel, Surendra Dasari, Naoki Oishi, et al.
Blood (2018) Vol. 132, Iss. 13, pp. 1386-1398
Open Access | Times Cited: 109
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
О. Ф. Гордеева
Seminars in Cancer Biology (2018) Vol. 53, pp. 75-89
Closed Access | Times Cited: 106
О. Ф. Гордеева
Seminars in Cancer Biology (2018) Vol. 53, pp. 75-89
Closed Access | Times Cited: 106
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
Jun S. Wei, Igor B. Kuznetsov, Shile Zhang, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 22, pp. 5673-5684
Open Access | Times Cited: 102
Jun S. Wei, Igor B. Kuznetsov, Shile Zhang, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 22, pp. 5673-5684
Open Access | Times Cited: 102
Profiling cancer testis antigens in non–small-cell lung cancer
Dijana Djureinovic, Björn M. Hallström, Masafumi Horie, et al.
JCI Insight (2016) Vol. 1, Iss. 10
Open Access | Times Cited: 100
Dijana Djureinovic, Björn M. Hallström, Masafumi Horie, et al.
JCI Insight (2016) Vol. 1, Iss. 10
Open Access | Times Cited: 100
Challenges and perspectives in the treatment of diabetes associated breast cancer
Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese, et al.
Cancer Treatment Reviews (2018) Vol. 70, pp. 98-111
Open Access | Times Cited: 100
Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese, et al.
Cancer Treatment Reviews (2018) Vol. 70, pp. 98-111
Open Access | Times Cited: 100
Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy
Rajarsi Mandal, Timothy A. Chan
Cancer Discovery (2016) Vol. 6, Iss. 7, pp. 703-713
Open Access | Times Cited: 95
Rajarsi Mandal, Timothy A. Chan
Cancer Discovery (2016) Vol. 6, Iss. 7, pp. 703-713
Open Access | Times Cited: 95
Cancer stem cells as targets for immunotherapy
Amy Codd, Takayuki Kanaseki, Toshihiko Torigo, et al.
Immunology (2017) Vol. 153, Iss. 3, pp. 304-314
Open Access | Times Cited: 93
Amy Codd, Takayuki Kanaseki, Toshihiko Torigo, et al.
Immunology (2017) Vol. 153, Iss. 3, pp. 304-314
Open Access | Times Cited: 93
Vitamin C – A new player in regulation of the cancer epigenome
Linn Gillberg, Andreas Due Ørskov, Minmin Liu, et al.
Seminars in Cancer Biology (2017) Vol. 51, pp. 59-67
Closed Access | Times Cited: 91
Linn Gillberg, Andreas Due Ørskov, Minmin Liu, et al.
Seminars in Cancer Biology (2017) Vol. 51, pp. 59-67
Closed Access | Times Cited: 91
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
Afsheen Raza, Maysaloun Merhi, Varghese Inchakalody, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 82
Afsheen Raza, Maysaloun Merhi, Varghese Inchakalody, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 82
FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells
Jia Shen, Zhixin Qiu, Qiulian Wu, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 352-369.e23
Open Access | Times Cited: 82
Jia Shen, Zhixin Qiu, Qiulian Wu, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 352-369.e23
Open Access | Times Cited: 82
Tumor microenvironment antigens
Mads Hald Andersen
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 253-264
Open Access | Times Cited: 47
Mads Hald Andersen
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 253-264
Open Access | Times Cited: 47
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines
Wei Jiao, Ai‐Min Hui
Cancer Treatment Reviews (2022) Vol. 107, pp. 102405-102405
Open Access | Times Cited: 42
Wei Jiao, Ai‐Min Hui
Cancer Treatment Reviews (2022) Vol. 107, pp. 102405-102405
Open Access | Times Cited: 42
The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?
Alaa Alsalloum, Julia Shevchenko, С. В. Сенников
Cancers (2023) Vol. 15, Iss. 6, pp. 1779-1779
Open Access | Times Cited: 27
Alaa Alsalloum, Julia Shevchenko, С. В. Сенников
Cancers (2023) Vol. 15, Iss. 6, pp. 1779-1779
Open Access | Times Cited: 27
In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma
Ashkan Safavi, Amirhosein Kefayat, Ardavan Abiri, et al.
Molecular Immunology (2019) Vol. 112, pp. 93-102
Closed Access | Times Cited: 75
Ashkan Safavi, Amirhosein Kefayat, Ardavan Abiri, et al.
Molecular Immunology (2019) Vol. 112, pp. 93-102
Closed Access | Times Cited: 75
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 846-846
Open Access | Times Cited: 73
Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 846-846
Open Access | Times Cited: 73